Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Singh S, Loke YK, Furberg CD.

JAMA. 2008 Sep 24;300(12):1439-50. doi: 10.1001/jama.300.12.1439. Review. Erratum in: JAMA. 2009 Mar 25;301(12):1227-30.

PMID:
18812535
2.

Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.

Salpeter SR.

Drugs. 2009 Oct 22;69(15):2025-33. doi: 10.2165/11318580-000000000-00000.

PMID:
19791824
3.

Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis.

Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA.

Respir Med. 2009 Oct;103(10):1421-9. doi: 10.1016/j.rmed.2009.05.020. Epub 2009 Jun 24. Review.

4.

Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.

Singh S, Loke YK, Enright P, Furberg CD.

Thorax. 2013 Jan;68(1):114-6. doi: 10.1136/thoraxjnl-2011-201275. Epub 2012 Jul 4. Review.

PMID:
22764216
5.

Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.

Singh S, Loke YK, Enright P, Furberg CD.

Postgrad Med J. 2014 Apr;90(1062):205-7. doi: 10.1136/postgradmedj-2011-201275rep.

PMID:
24643260
6.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Epub 2009 Jul 20. Review.

7.

Cardiovascular safety of tiotropium in patients with COPD.

Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP.

Chest. 2010 Jan;137(1):20-30. doi: 10.1378/chest.09-0011. Epub 2009 Jul 10.

PMID:
19592475
8.

[Are there cardiovascular adverse effects of inhaled anticholinergics?].

Nagy LB.

Orv Hetil. 2015 Aug 2;156(31):1246-52. doi: 10.1556/650.2015.30198. Review. Hungarian.

PMID:
26211748
9.

Inhaled tiotropium for stable chronic obstructive pulmonary disease.

Barr RG, Bourbeau J, Camargo CA, Ram FS.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002876. Review.

PMID:
15846642
10.

Contemporary management of chronic obstructive pulmonary disease: scientific review.

Sin DD, McAlister FA, Man SF, Anthonisen NR.

JAMA. 2003 Nov 5;290(17):2301-12. Review.

PMID:
14600189
11.

Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.

Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.

JAMA Intern Med. 2013 Jul 8;173(13):1175-85. doi: 10.1001/jamainternmed.2013.1016.

PMID:
23689820
12.

Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients.

Rottenkolber M, Rottenkolber D, Fischer R, Ibáñez L, Fortuny J, Ballarin E, Sabaté M, Ferrer P, Thürmann P, Hasford J, Schmiedl S.

Respir Med. 2014 Aug;108(8):1075-90. doi: 10.1016/j.rmed.2014.05.014. Epub 2014 Jun 5. Review.

13.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
14.
15.

Anticholinergic treatment in airways diseases.

Flynn RA, Glynn DA, Kennedy MP.

Adv Ther. 2009 Oct;26(10):908-19. doi: 10.1007/s12325-009-0074-x. Epub 2009 Nov 27. Review.

PMID:
19967500
16.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.

17.

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.

Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S.

Int J Chron Obstruct Pulmon Dis. 2011;6:269-75. doi: 10.2147/COPD.S17864. Epub 2011 May 9.

18.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
19.
20.

Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD.

Loke YK, Kwok CS, Singh S.

Eur Respir J. 2010 May;35(5):1003-21. doi: 10.1183/09031936.00095909. Epub 2009 Nov 19. Review.

Items per page

Supplemental Content

Write to the Help Desk